ESTRO37_ProgrammeBook

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

POSTERS

B. Movsas, I. Chetty

 PO-0750

> Radiomic feature changes in small cell lung cancer IGRT relate significantly to overall survival G. Price (United Kingdom), A. McWilliam, J. O’Connor, M. Van Herk, C. Faivre-Finn > Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study K. Haslett (United Kingdom), L. Ashcroft, N. Bayman, K. Franks, N. Groom, G. Hanna, S. Harden, C. Harris, S. Harrow, M. Hatton, P. McCloskey, F. McDonald, D. Ryder, C. Faivre-Finn > Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC K. Haslett (United Kingdom), F. Blackhall, P. Koh, L. Ashcroft, M. Asselin, C. Harris, A. Jackson, P. Manoharan, D. Mullan, W. Ryder, B. Taylor, C. Faivre-Finn > Safe inhomogeneus RT dose escalation in locally advanced NSCLC, -interim results from NARLAL2 T. Schytte (Denmark), T. Nielsen, D. Moeller, L. Hoffmann, A. Khalil, M. Knap, M. Lund, C. Nyhus, T. Hansen, W. Ottosson, S. Borissova, A. Appelt, C. Brimk, O. Hansen > Can dose proximal to the PTV influence the risk of distant metastases in SBRT lung cancer patients? A. Diamant (Canada), A. Chatterjee, I. El Naqa, H. Bahig, E. Filion, C. Robinson, S. Faria, H. Al-Halabi, K. Adil, J. Seuntjens > Respiration control by hypnosis during radiotherapy of lung cancer: A preclinical and clinical trial Y. Liu (China), R. Li, Y. Xie > Non-small cell lung cancer decision support based on distributed learning over multi-center data M. Field (Australia), L. Holloway, S. Vinod, M.S. Barakat, V. Ahern, M. Bailey, M. Carolan, G. Delaney, A. Ghose, E. Hau, J. Lehmann, T. Lustberg, A.A. Miller, J. Van Soest, D. Stirling, J. Sykes, S. Walsh, A. Dekker, D.I. Thwaites

 PO-0751

 PO-0752

 PO-0753

 PO-0754

 PO-0755

 PO-0756

 PO-0757

Programme and Exhibition Guide | POSTERS AND ELECTRONIC POSTERS

197